Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-9193

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease ; volume:12 ; number:1 ; day:23 ; month:9 ; year:2020 ; pages:1-11 ; date:12.2020
Alzheimer's research & therapy ; 12, Heft 1 (23.9.2020), 1-11, 12.2020

Creator: Cho, Hanna
Baek, Min Seok
Lee, Hye Sun
Lee, Jae Hoon
Ryu, Young Hoon
Lyoo, Chul Hyoung

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13195-020-00685-4

URN: urn:nbn:de:101:1-2020111122003996649398

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Cho, Hanna
Baek, Min Seok
Lee, Hye Sun
Lee, Jae Hoon
Ryu, Young Hoon
Lyoo, Chul Hyoung
SpringerLink (Online service)

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Combining connectivity, related pathologies, and genetic factors to explain tau accumulation in Alzheimer’s disease

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Combining connectivity, related pathologies, and genetic factors to explain tau accumulation in Alzheimer’s disease

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Combining connectivity, related pathologies, and genetic factors to explain tau accumulation in Alzheimer’s disease

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Combining connectivity, related pathologies, and genetic factors to explain tau accumulation in Alzheimer’s disease

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Combining connectivity, related pathologies, and genetic factors to explain tau accumulation in Alzheimer’s disease

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Combining connectivity, related pathologies, and genetic factors to explain tau accumulation in Alzheimer’s disease

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Related objects

Reset password